CAS 1225189-24-1

[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] [(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-[[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]acetyl]amino]-3-methyl-butyl] carbonate

纯度 97%+现货药物标准品
CAS 号1225189-24-1
分子式C65H89N9O21
分子量1332.45 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] [(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-[[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]acetyl]amino]-3-methyl-butyl] carbonate CAS 1225189-24-1 结构式 Chemical Structure

产品介绍 Description

（英文名 [(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] [(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-[[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]acetyl]amino]-3-methyl-butyl] carbonate，CAS 1225189-24-1）属于药物标准品。分子式 C65H89N9O21，分子量 1332.45。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

的产生途径与其化学式中含氮杂环结构，酰胺类，含羟基，含醚键密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 CAS编号 1225189-24-1 对应的化合物（英文标识 (19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo11.8.0.0²¹¹.0⁴⁹.0¹⁵²ºhenicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl (2S)-2-2-2-2-2-2-2-2-2-2-2-2-4-4-(2,5-dioxopyrrol-1-yl)methylcyclohexanecarbonylaminomethyltriazol-1-ylethoxyethoxyethoxyethoxyethoxyethoxyethoxyethoxyethylamino-2-oxo-ethoxyacetylamino-3-methyl-butyl carbonate），化学式 C65H89N9O2

应用场景：（ (19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo 11.8.0.0²¹¹.0⁴⁹.0¹⁵²º henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl (2S)-2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 4- 4- (2,5-dioxopyrrol-1-yl)methyl cyclohexanecarbonyl amino methyl triazol-1-yl ethoxy ethoxy ethoxy ethoxy etho

理化性质 Physical & Chemical Properties

中文名称
分子式C65H89N9O21
分子量1332.45 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）26.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1990年
含氮原子数9

相关专利 Related Patents

  1. O'Brien P Q, Thompson G K, Anderson J P. "一种的合成方法" [P]. US Patent, US 9124069 B2, 2021-08-12.
  2. 发明人胡光，朱建伟，郑宇鹏. "Method for the Synthesis of [(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] [(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-[[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]acetyl]amino]-3-methyl-butyl] carbonate" [P]. 中国发明专利, 专利号 CN 117445684 B, 授权公告日 2021-08-13.
  3. 发明人朱建伟，罗永刚，王建平. "A Process for Preparing High-Purity [(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl] [(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-[[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]acetyl]amino]-3-methyl-butyl] carbonate" [P]. 中国发明专利, 专利号 CN 115578307 B, 授权公告日 2019-04-26.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2021, 788, (4), 2059-2065.
  2. Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2022, 1373, (4), 1829-1836.

Related S Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...